Home Search
chronic pain - search results
If you're not happy with the results, please do another search
COVID-19 and medical cannabis: Could the crisis bring opportunities?
John Binns, Partner at BCL Solicitors LLP, provides us with fresh insight into COVID-19 and medical cannabis. He ponders if the crisis could bring opportunities for the industry.
The great need for Analgesic innovation: 1 in 4 of us are waiting
Here, Mark J. Field M.Sc. FRSB, FIScT, MRPharmS, Owner and Founder of Analgesic Innovation, discusses the ever-pressing need for Analgesic Innovation.
Healing with cannabinoids: MS and Prostate Cancer
Dr Shiksha Gallow, Medical Director of Biodata and Head Researcher at Cannabis Oil Research, provides evidence-based research on cannabinoids for treating MS and Prostate Cancer.
Why is it so hard to determine which CBD products to buy?
Jade Mansfield from British CBD Company, explains why it is so hard to know which CBD products to buy since its growth in popularity.
How can cannabis help in treating anxiety?
Today, people use cannabis products such as CBD for numerous medicinal benefits, here we find out how it can help in treating anxiety.
Medical use of cannabinoids and marijuana
In this article, Dr Gerry Morrow shares his thoughts on the medical use of cannabinoids and marijuana.
A World Health Organization perspective on cannabidiol (CBD)
Here, we discover the World Health Organization perspective on cannabidiol (CBD), including how there has been a shift in how CBD is socially perceived following reports and recommendations.
From Cannabis flower to final products: Extractions for Phytopharmaceuticals
Dr Nikos Xynos, PhD in Pharmaceutical Sciences/Natural Products Chemistry and MD a Nomad Labs, explores the various pathways to cannabinoid extraction, refining and purification technologies.
The UK’s medical cannabis industry
Dr. Frank D'Ambrosio, CMO of Block Commodities Plc, provides an insight into the UK’s medical cannabis industry.
An insight into the CBD drinks market
Jade Mansfield from The British CBD Company, provides an insight into the CBD drinks market with a focus on trends, investments and drawbacks.
What is the difference between cannabidiol and THC?
Dr Diana Gall (MD), GP at Doctor4U tells us the difference between cannabidiol and THC.
Cannabinoids and health – from supplements to medicines
GreenLight Medicines is a supplier of quality supplements and is an active MedCan research company GreenLight, Supplements and Medicines.
The Academy of Medical Cannabis
Professor Mike Barnes, Director of Education at The Academy of Medical Cannabis shares his thoughts on the rescheduling of cannabis to a Schedule II substance in November of 2018 and access to medical cannabis prescriptions.
Medical marijuana: Developments in the industry
Ian C Tordoff, CEO of Block Commodities Ltd, provides a snap-shot of changes in the medical marijuana industry.
Tackling the growing burden of brain disorders in Europe
Frédéric Destrebecq, Executive Director of the European Brain Council explains the importance of tackling the growing burden of brain disorders in Europe.
Impact and early intervention: Clinical research into osteoarthritis
Versus Arthritis speaks to award-winning rheumatologist Dr Fiona Watt about clinical research into osteoarthritis.
UK and Ireland medical cannabis access programmes and education slowly progress
GreenLight Pharmaceuticals Ltd is advancing clinical research and education in UK and Ireland; Though government progress on access and prescribing recommendations lags behind much of Europe.
Medicine authority can’t recommend CBD medicines to NHS
The National Institute for Health and Care Excellence (NICE) said they need more research into CBD medicines before the NHS can prescribe them in general.
Why cannabidiol really is the next big thing
From the stories appearing about CBD and its near miraculous effects, to the pharmaceutical companies rushing to catch up, it seems everyone is taking about cannabidiol.
Medicinal cannabis requires further clinical research and educational support
Dr Mark Ware, Chief Medical Officer at Canopy Growth, provides an overview of the research that already exists around medicinal cannabis and explains why there is a need to educate clinicians further.